-
Product Insights
Inhalers Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Inhalers Pipeline Market Report Overview Inhalers deliver medication to the lungs. The inhalers pipeline market research report provides a comprehensive understanding of the pipeline products along with their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Segment ·       Dry Powder Inhaler Devices Key Territories ·       The US ·       Europe ·       Australia...
-
Product Insights
Dry Powder Inhaler Devices Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Dry Powder Inhaler Devices Pipeline Market Report Overview Dry powder inhaler devices deliver medication to the lungs in the form of a dry powder. The Dry Powder Inhaler Devices pipeline market research report provides comprehensive information about the Dry Powder Inhaler Devices pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Territories ·       The US ·       China ·       Europe ·       Global ·       Australia Key...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Nanodox in Atopic Dermatitis (Atopic Eczema)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Nanodox in Atopic Dermatitis (Atopic Eczema) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.NanoDOX in Atopic Dermatitis (Atopic Eczema) Drug Details:NanoDOX is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ascrinvacumab in Solid Tumor
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ascrinvacumab in Solid Tumor report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ascrinvacumab in Solid Tumor Drug Details: Ascrinvacumab (PF-03446962) is under development...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – NTO-1151 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - NTO-1151 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) report and make more profitable business decisions. This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. NTO-1151 in Neuroendocrine Gastroenteropancreatic Tumors (GEP-NET) Drug Details: Triapine...
-
Sector Analysis
Mergers and Acquisitions (M&A) in the Contract Manufacturing Industry – Implications and Outlook – 2023 Edition
M and A In Pharmaceutical Contract Manufacturing Industry Report Overview During 2018–22, contract manufacturing organization (CMO) merger and acquisition (M&A) deal activity increased, and the targeted manufacturers have adopted specialized capabilities such as controlled substance and containment manufacture. Despite considerable macroeconomic challenges for pharma manufacturers, 2021–22 witnessed strong M&A activity and CMO valuations, although there was a slight decline in CMO M&A activity in 2022 due to rising inflation and interest rates. The Mergers and Acquisitions (M&A) in the Contract...
-
Product Insights
Influenza A Virus, H7N9 Subtype Infections Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Influenza A Virus, H7N9 Subtype Infections Pipeline Drugs Market Report Overview Avian influenza A (H7N9) is a subtype of influenza viruses. This infection is seen both in humans and birds. Infection is caused when a person is exposure to infected poultry or contaminated environments. Symptoms include fever, cough that produces sputum, headache, myalgia, and general malaise. Treatment includes antiviral drugs. The Influenza A Virus, H7N9 Subtype Infections pipeline drugs market research report provides comprehensive information on the Influenza A Virus,...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NanoDOX
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry NanoDOX Drug Details NanoDOX is under development for the treatment of atopic dermatitis. The...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – PRX-3140
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry PRX-3140 Drug Details PRX-03140 (NTC-942) is under development for the treatment of Alzheimer's disease. It is...
-
Product Insights
Likelihood of Approval and Phase Transition Success Rate Model – NTO-1151
Overview How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data to allow you to track and predict specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using a combination of machine learning and proprietary models. Likelihood of Approval (LoA) - Industry NTO-1151 Drug Details Triapine (NTO-1151) is under development for the treatment of neuroendocrine gastroenteropancreatic...